Healthcare & Life Sciences
Neurogastrx, Inc.
Israelneurogastrx.com/
Neurogastrx, Inc. is a Healthcare & Life Sciences startup based in Israel, most recent round Series B, 3 tracked investors.
unknownseries-b
series-b
Stage
3
Investors
About Neurogastrx, Inc.
Based in Israel, Neurogastrx, Inc. is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Neurogastrx is a privately held, clinical-stage biopharmaceutical company developing therapies for serious gastrointestinal diseases. Its lead program, NG101, is an oral, peripherally acting dopamine D2 receptor antagonist being studied for gastroparesis and nausea/vomiting associated with GLP-1 agonists.
Explore Neurogastrx, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.